{"timestamp": 1771594806.7997897, "value": {"ticker": "XLO", "company_name": "Xilio Therapeutics, Inc.", "short_name": "Xilio Therapeutics, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 41870604, "float_shares": 10671742, "shares_outstanding": 73457202, "short_ratio": 4.99, "short_percent_of_float": 0.042, "shares_short": 2139403, "shares_short_prior": 2168608, "insider_percent_held": 0.3534, "institution_percent_held": 0.42423, "total_cash": 103764000, "total_debt": 7263000, "total_revenue": 31804000, "revenue_growth": 7.425, "earnings_growth": 0, "profit_margins": -1.8390499, "gross_margins": 0.82575, "operating_margins": -0.101169996, "debt_to_equity": 0, "current_ratio": 2.2, "book_value": -0.156, "price_to_book": -3.653846, "operating_cashflow": -17151000, "free_cashflow": -20778876, "price": 0.57, "52w_high": 1.215, "52w_low": 0.503, "avg_volume": 480721, "avg_volume_10d": 605220, "full_time_employees": 64, "audit_risk": 0, "overall_risk": 0}}